Ligand ID: K86 Drugbank ID: DB00559(Bosentan) Indication:Used in the treatment of pulmonary arterial hypertension (PAH), to improve exercise ability and to decrease the rate of clinical worsening (in patients with WHO Class III or IV symptoms). |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127LEU A 153ILE A 18ALA A 154 | 1.73A | 16.49 | APR A 201 (-3.7A)NoneNoneNoneAPR A 201 (-4.5A) | ||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | VAL A6865LEU A7050LEU A6852ILE A7005ALA A6966 | 1.69A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127LEU A 153ILE A 18ALA A 154 | 1.71A | AMP A 201 ( 3.7A)NoneNoneNoneAMP A 201 ( 4.5A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127LEU B 153ILE B 18ALA B 154 | 1.70A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | VAL A6865LEU A7050LEU A6852ILE A7005ALA A6966 | 1.68A | 15.38 | None | ||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127LEU A 153ILE A 18ALA A 154 | 1.78A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127LEU A 153ILE A 18ALA A 154 | 1.78A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | VAL A6865LEU A7050LEU A6852ILE A7005ALA A6966 | 1.67A | NoneFMT A7107 (-4.7A)NoneNoneNone | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | VAL A6865LEU A7050LEU A6852ILE A7005ALA A6966 | 1.67A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | VAL C6865LEU C7050LEU C6852ILE C7005ALA C6966 | 1.68A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | VAL A6865LEU A7050LEU A6852ILE A7005ALA A6966 | 1.68A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 49LEU E 127LEU E 153ILE E 18ALA E 154 | 1.76A | NoneNoneNoneNoneEDO E 205 (-4.4A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127LEU A 153ILE A 18ALA A 154 | 1.78A | NoneEDO A 202 ( 4.8A)NoneNoneNone | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127LEU C 153ILE C 18ALA C 154 | 1.79A | None | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 49LEU D 127LEU D 153ILE D 18ALA D 154 | 1.78A | EDO D 209 (-4.6A)NoneNoneNoneEDO D 208 (-4.2A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127LEU B 153ILE B 18ALA B 154 | 1.79A | APR B 201 (-3.7A)NoneNoneNoneAPR B 201 (-4.5A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 49LEU E 127LEU E 153ILE E 18ALA E 154 | 1.74A | APR E 201 (-3.7A)NoneNoneNoneAPR E 201 (-4.5A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127LEU A 153ILE A 18ALA A 154 | 1.76A | APR A 201 (-3.7A)NoneNoneNoneAPR A 201 (-4.4A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127LEU C 153ILE C 18ALA C 154 | 1.77A | APR C 201 (-3.6A)NoneNoneNoneAPR C 201 (-4.5A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 49LEU D 127LEU D 153ILE D 18ALA D 154 | 1.77A | APR D 201 (-3.7A)NoneNoneNoneAPR D 201 (-4.5A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 49LEU B 127LEU B 153ILE B 18ALA B 154 | 1.75A | NoneNoneNoneNoneEDO B 202 (-4.3A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL C 49LEU C 127LEU C 153ILE C 18ALA C 154 | 1.79A | NoneNoneNoneNoneEDO C 206 (-4.4A) | |||
![]() | 5XPR_A_K86A1201_1 (ENDOTHELIN BRECEPTOR,ENDOLYSIN,ENDOTHELIN B RECEPTOR) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL A 49LEU A 127LEU A 153ILE A 18ALA A 154 | 1.77A | None |